首页> 外文期刊>The Journal of pediatrics >Burkitt's lymphoma in a patient with adenosine deaminase deficiency-severe combined immunodeficiency treated with polyethylene glycol-adenosine deaminase.
【24h】

Burkitt's lymphoma in a patient with adenosine deaminase deficiency-severe combined immunodeficiency treated with polyethylene glycol-adenosine deaminase.

机译:患有腺苷脱氨酶缺乏症-重度合并免疫缺陷的患者的伯基特淋巴瘤,用聚乙二醇-腺苷脱氨酶治疗。

获取原文
获取原文并翻译 | 示例
           

摘要

We describe a patient with severe combined immunodeficiency because of aberrations in adenosine deaminase (ADA) who despite adequate replacement with polyethylene glycol-linked ADA (PEG-ADA) for 13 years developed Burkitt's lymphoma. Although treatment corrected the metabolic abnormalities caused by ADA deficiency, it failed to fully restore cellular immunity.
机译:我们描述了由于腺苷脱氨酶(ADA)异常而患有严重的联合免疫缺陷症的患者,尽管用聚乙二醇连接的ADA(PEG-ADA)进行了13年的充分替代,但仍发生了伯基特氏淋巴瘤。尽管治疗纠正了由ADA缺乏引起的代谢异常,但未能完全恢复细胞免疫。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号